CAMP
CAMP4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural
Analyst coverage shows 2 buys and 1 neutral, with mixed historical performance. Fund‑flow score is 7.81/10, indicating strong inflows across most investor sizes except small traders. Sentiment is neutral (5.75). Overall, liquidity is healthy but analyst confidence is modest.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
67%
Hold
0%
Sell
0%
Strong Sell
0%
Anupam RamaNeutral
Date2025-09-16
InstitutionJP Morgan
Times predicted1
Historical Win Rate0.0%
Edward TenthoffBuy
Steve SeedhouseBuy
What is the market sentiment for CAMP?
- CAMP holds a Bearish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).
